![Katharine Hsu and Rosa Sottile](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/233818/main_image/hsusottile_1200x800.jpg)
Unusual Immune Cell Type Could Be Good Target for Immunotherapy
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
![Katharine Hsu](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/221971/main_image/katharine-hsu-120126-19-1200x800.jpg)
Dr. Katharine Hsu Named Director of Tri-Institutional M.D.-Ph.D. Program
In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.
In the Lab
![Pictured: Natural Killer Cells & Cancer Cell](https://www.sloankettering.edu/sites/default/files/styles/width_200/public/node/17807/image/hsu-princ-s6641.jpg)
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.